Remove Doctors Remove Licensing Remove Vaccine
article thumbnail

Retired Doctors, Nurses Will Be Approved to Give COVID-19 Vaccine, White House Says

The Pharma Data

Retired Doctors, Nurses Will Be Approved to Give COVID-19 Vaccine, White House Says. 27, 2021 — Retired doctors and nurses are being called to the front lines of the U.S. COVID-19 vaccination effort, the White House COVID-19 Response team announced Wednesday. Professional. WEDNESDAY, Jan. director of the U.S.

Nurses 52
article thumbnail

Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November

The Pharma Data

Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the US will be ready by November. . But Slaoui did say that he believes a vaccine will be available by the end of the year, and could possibly vaccinate between 20 and 25 million people.

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO and Partners to Stockpile Ebola Vaccine

The Pharma Data

WHO and Partners to Stockpile Ebola Vaccine. 12, 2021 — Ebola vaccines are being stockpiled by the World Health Organization and other groups to combat future outbreaks of the deadly disease. TUESDAY, Jan. Nearly 7,000 doses are currently available. Associated Press Article. © 2021 HealthDay.

Vaccine 52
article thumbnail

Coronavirus: Health workers' army to be trained to deliver Covid vaccine

The Pharma Data

The government plans to train up an army of health professionals to be ready to give the coronavirus vaccine, if and when one is shown to work. This could include pharmacists, who already deliver flu vaccines, midwives and physiotherapists. But a vaccine is not expected to be ready before Christmas.

Vaccine 52
article thumbnail

FDA Will Follow The Science On COVID-19 Vaccines For Young Children

The Pharma Data

Many parents have questions on COVID-19 and when vaccines are going to be available for youngsters younger than 12 years aged. We are therefore also wanting to see COVID-19 vaccines available for young children. Some have stated that they’re still enrolling, and a few are still administering doses or following participants.

Vaccine 52
article thumbnail

The Pharma Data - Untitled Article

The Pharma Data

SK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic adjuvant, to the Korean Ministry of Food and Drug Safety (KMFDS) following positive Phase III clinical data.

article thumbnail

Dr. Kent R. Van Kampen Celebrated for Dedication to the Field of Pharmaceutical Research

The Pharma Data

Van Kampen excels as the chief executive officer of The Van Kampen Group, which assists other companies in research and liaisons with government and industry regarding licensing products for commercial use. Nearly 30 years later, he was awarded an Honorary Doctorate Degree from Utah State University.